Neng Ye

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Low Contact Thermal Resistance without Packaging Pressure in Highly Thermally Conductive Interface Materials Enabled by Polysulfide Vitrimer.

Low Contact Thermal Resistance without Packaging Pressure in Highly Thermally Conductive Interface Materials Enabled by Polysulfide Vitrimer.

Journal: Nano letters

Published: December 04, 2025

Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis.

Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis.

Journal: Journal of pharmaceutical analysis

Published: June 30, 2025

Valtrate alleviates inflammation by targeting USP9X to enhance NLRP3 degradation.

Valtrate alleviates inflammation by targeting USP9X to enhance NLRP3 degradation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 05, 2025

Mechanisms and therapeutic strategies for NLRP3 degradation via post-translational modifications in ubiquitin-proteasome and autophagy lysosomal pathway.

Mechanisms and therapeutic strategies for NLRP3 degradation via post-translational modifications in ubiquitin-proteasome and autophagy lysosomal pathway.

Journal: European journal of medicinal chemistry

Published: December 13, 2024

Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease.

Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: September 23, 2024

Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization.

Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization.

Journal: Journal of medicinal chemistry

Published: April 30, 2024

NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation.

NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation.

Journal: Science advances

Published: February 07, 2024

Exploring the Immunomodulatory Properties of Red Onion (Allium cepa L.) Skin: Isolation, Structural Elucidation, and Bioactivity Study of Novel Onion Chalcones Targeting the A2A Adenosine Receptor.

Exploring the Immunomodulatory Properties of Red Onion (Allium cepa L.) Skin: Isolation, Structural Elucidation, and Bioactivity Study of Novel Onion Chalcones Targeting the A2A Adenosine Receptor.

Journal: Journal of agricultural and food chemistry

Published: November 06, 2023

Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition.

Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition.

Journal: Journal of medicinal chemistry

Published: October 25, 2023

Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis.

Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis.

Journal: Journal of medicinal chemistry

Published: September 27, 2023

Design, Synthesis, and Biological Evaluation of Novel P2X7 Receptor Antagonists for the Treatment of Septic Acute Kidney Injury.

Design, Synthesis, and Biological Evaluation of Novel P2X7 Receptor Antagonists for the Treatment of Septic Acute Kidney Injury.

Journal: Journal of medicinal chemistry

Published: August 15, 2023

From lead to clinic: A review of the structural design of P2X7R antagonists.

From lead to clinic: A review of the structural design of P2X7R antagonists.

Journal: European journal of medicinal chemistry

Published: January 03, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026